Alcohol Brief Intervention Plus Personalized Mobile Chat-based Intervention to Reduce Alcohol Misuse in an Emergency Department

September 24, 2019 updated by: Dr. Wang Man-Ping, The University of Hong Kong

A Pilot Study on the Feasibility of Alcohol Brief Intervention Plus Personalized Mobile Chat-based Intervention to Reduce Alcohol Misuse in an Emergency Department in Hong Kong

This project focuses on patients in AED. Objectives of this project are:

  1. To examine the factors associated with alcohol drinking and alcohol use disorder
  2. To examine the effect of face-to-face alcohol brief intervention on drinking reduction
  3. To examine the effect of a continuous interactive chat-based intervention via "WhatsApp" on drinking reduction
  4. To explore the perception of face-to-face alcohol brief intervention
  5. To explore the perception of continuous interactive chat-based intervention via instant messaging mobile application "WhatsApp"

Study Overview

Detailed Description

According to the Department of Health, a local epidemiological study was conducted in 2001 and showed that about one in ten of all motor vehicle deaths were associated with alcohol consumption. Also, the statistics from the Transportation department showed that 874 vehicle accidents resulting in personal injury were related to alcohol misuse, which included 24 fatal cases between the period of 2000 and 2010. With the aforementioned statistics supported, the hospital Accident and Emergency Department (AED) serves as the most important entrance and safeguard to the healthcare system for the public, since victims of traffic accidents or violence related to heavy drinking are frequently encountered in AED, this serves as an ideal place for provision of initial alcohol intervention and further stabilization related to alcohol problem of patients. Although AED is a hectic environment with very high patients turnover, substantial evidence had shown feasibility and efficacy of Alcohol Brief Intervention (ABI) in reducing patients' subsequent alcohol drinking. In oversea, multiple research had been done to show ABI were effective and feasible for reducing alcohol misuse, but the effect was not long lasting and lead to subsequent relapse. In addition to this, no further trial has been done to investigate the feasibility of implementing an RCT on evaluating the effect of ABI and continuous chat-based intervention on reducing alcohol consumption among patients in AED in Hong Kong.

According to the WHO, the standard ABI approach includes: giving feedback and information about the screening result and hazard of drinking; emphasizing the benefits of quit drinking and informing about alcohol problems; setting goal on reducing alcohol consumption; reviewing advice and ; giving encouragement. In this pilot study, a brief alcohol counselling using face-to-face ABI will be delivered together with continuous interactive chat-based intervention via instant messaging mobile application "WhatsApp" to those patients with AUDIT score ≥ 8, who are considered to have hazardous and harmful drinking problems according to the guideline.

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Hong Kong, Hong Kong, 000000
        • School of Nursing, The University of Hong Kong

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Hong Kong resident aged 18 to 65
  2. scored ≥ 8 in the Alcohol Use Disorder Identification Test (AUDIT) in the past 12 months
  3. able to communicate in Cantonese (including reading Chinese)
  4. using a phone with instant messaging mobile application "WhatsApp" installed for communication.

Exclusion Criteria:

  1. patients with communication barrier (either physically or cognitively)
  2. currently participating in other alcohol treatment services or clinics
  3. will be hospitalized immediate after A&E consultation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention group
Alcohol brief intervention+mobile chat-based instant messages
Subjects in the active arm study will receive 5-minute face-to-face ABI, alcohol leaflet from Department of Health (DH) plus continuous interactive chat-based intervention for 1 month as an extension of alcohol brief intervention at baseline
The Control group will receive face-to-face ABI plus an alcohol leaflet from DH.
Active Comparator: control group
Alcohol brief intervention
The Control group will receive face-to-face ABI plus an alcohol leaflet from DH.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change in unit of alcohol consumption in gram
Time Frame: at 3-month after baseline.
Assessed by unit in gram and compare the alcohol consumption between intervention and control group at 3-month after baseline.
at 3-month after baseline.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change in unit of alcohol consumption in gram
Time Frame: at 1-month after phase I
Assessed by unit in gram and compare the alcohol consumption between intervention and control group at 1-month after phase I
at 1-month after phase I
change in episode of binge drinking measured by asking "Never", "less than a month", "two to four times a month", " two to three times a week" and "almost everyday"
Time Frame: at 1 and 3 months after phase I
Defined by 5 [male] or 4 [female] in a row for binge drinking and compare the episode of binge drinking between intervention group and control at baseline, 1 and 3-month follow-up questionnaires
at 1 and 3 months after phase I
change in frequency of drinking by asking "Never", "less than a month", "two to four times a month", " two to three times a week" and "almost everyday"
Time Frame: at 1 and 3 months after phase I
Compare the frequency of drinking between intervention group and control at baseline, 1 and 3-month follow-up questionnaires
at 1 and 3 months after phase I
attempt to reduce drinking measured by asking whether they have tried to reduce drinking at past month (yes or no)
Time Frame: at 1 and 3 months after phase I
Compare the attempt to reduce drinking between intervention group and control group at baseline, 1 and 3-month follow-up questionnaires
at 1 and 3 months after phase I
change in confidence to reduce drinking measured by Likert scale (1-10)
Time Frame: at 1 and 3 months after phase I
Score ranges from 0 to 10 with higher score indicates a high level. The score will be compared between intervention group and control group at baseline, 1 and 3-month follow-up questionnaires
at 1 and 3 months after phase I
Alcohol Problems Scale at 1 and 3-month follow-up
Time Frame: at 1 and 3 months after phase I
The 14-item measure of alcohol-related personal, social, sexual, and legal problems (eg, being physically aggressive toward someone while under the influence of alcohol).The score will be compared between intervention group and control group at baseline, 1 and 3-month follow-up questionnaires
at 1 and 3 months after phase I

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2019

Primary Completion (Actual)

April 30, 2019

Study Completion (Actual)

May 30, 2019

Study Registration Dates

First Submitted

January 27, 2019

First Submitted That Met QC Criteria

January 29, 2019

First Posted (Actual)

January 30, 2019

Study Record Updates

Last Update Posted (Actual)

September 26, 2019

Last Update Submitted That Met QC Criteria

September 24, 2019

Last Verified

September 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Alcohol Use Disorder

Clinical Trials on Mobile chat-based instant messages

3
Subscribe